Markets

Sun Pharma Launches Semaglutide Injections in India Under Noveltreat and Sematrinity Brands Mumbai, India, March 21, 2026 – Sun Pharmaceutical Industries Limited today announced the launch of its semaglutide injection under the brand names Noveltreat and Sematrinity in India, available in all strengths. Noveltreat is indicated for chronic weight management in adults as an adjunct to a reduced-calorie diet & increased physical activity and is available in five dose strengths - 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 1.7 mg/0.75 mL, and 2.4 mg/0.75 mL. Sematrinity is indicated for treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet & exercise and is available in two dose strengths - 2...

Hind Rectifiers Limited Sets Record Date for Bonus Equity Share Allotment Hind Rectifiers Limited announced March 20, 2026, as the record date for the allotment of bonus equity shares. The decision follows a board recommendation from February 11, 2026, to issue one new equity share worth Rs. 10 for every existing equity share valued at Rs. 2. Shareholders approved the bonus share issue via postal ballot.The deemed date of allotment for the 1,71,83,807 new equity shares is March 30, 2026, with trading of the bonus shares expected to begin on March 31, 2026.Anil Kumar Nemani, Chief Financial Officer, confirmed the details on behalf of Hind Rectifiers Limited.Source:

Waaree Energies Limited Announces Leadership Changes Waaree Energies Limited announced several leadership changes following a board meeting held on March 20, 2026.Amit Ashok Paithankar has stepped down from his position as Whole-Time Director and Chief Executive Officer, effective March 20, 2026, which is prior to the previously announced date of May 15, 2026. Mr. Jignesh Devchandbhai Rathod, currently CEO-Designate, has been appointed as Whole-Time Director and Chief Executive Officer, effective March 21, 2026, pending shareholder approval. Mr. Rathod holds a bachelor's degree in engineering, a master's degree in business administration, and a doctorate in business administration. He has been associated with the company since...

Havells India Receives Customs Order, Plans Appeal Havells India Limited announced it has received an order from the Commissioner of Customs, ICD TKD - Import, New Delhi, dated March 13, 2026. The order, received on March 20, 2026, pertains to the period from May 2020 to July 2023.The order raises a demand of Rs. 20,236,992, comprising Rs. 10,118,496 in Customs Duty and Rs. 10,118,496 in penalties. The demand stems from a dispute regarding the classification of certain imported goods.According to Havells India, in consultation with its tax advisors, the company believes the demand is not legally sustainable and intends to file an appeal under the applicable provisions of the Customs Act. The company stated that the order is not...

Citizen Infoline Ltd. Receives NCLT Approval for Amalgamation of Citizen Solar Private Limited Citizen Infoline Ltd. (BSE: 538786) announced that the National Company Law Tribunal (NCLT), Ahmedabad Bench (Court-II), has approved and sanctioned the Scheme of Amalgamation of Citizen Solar Private Limited (Transferor Company) with Citizen Infoline Limited (Transferee Company) under Sections 230 to 232 of the Companies Act, 2013.The NCLT order was delivered on March 19, 2026. The appointed date for the amalgamation is April 1, 2023, while the effective date will be the date of filing a certified copy of the order with the Registrar of Companies (RoC).Key details of the Scheme include:Transfer of all assets, liabilities, rights, and...

Dr. Reddy's Laboratories Launches India's First DCGI-Approved Semaglutide Injection 'Obeda ®' for Type 2 Diabetes Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced the launch of its injectable semaglutide under the brand name Obeda®, marking an entry into the GLP-1 receptor agonists therapy space in India. The company received Drugs Controller General of India (DCGI) approval for generic semaglutide.The announcement underscores Dr. Reddy's readiness to serve unmet patient needs in India, addressing the country's significant diabetes burden, where over 101 million adults live with the condition.In a Phase-III clinical study, Dr. Reddy's Obeda ® demonstrated non-inferior efficacy and...

Solarium Green Energy Limited Receives Purchase Orders Valued at ₹22.51 Crores Solarium Green Energy Limited (Security Id.: SOLARIUM, Security Code: 544354) announced it has received two purchase orders totaling approximately ₹22,50,98,308/- (Rupees Twenty-Two Crore Fifty Lakh Ninety-Eight Thousand Three Hundred Eight Only), exclusive of GST.The first purchase order, dated March 20, 2026, is for the supply of BIS-certified 715/720 Wp Topcon N-type Bifacial Dual Glass Solar Panels for grid connected solar projects in Karnataka, Tamil Nadu, and Andhra Pradesh. The order value is approximately ₹14,10,09,940/- (Rupees Fourteen Crore Ten Lakh Nine Thousand Nine Hundred Forty Rupees Only).A second purchase order, received on March 19...

Zydus Launches Semaglutide Injection in India with Innovative Pen Device Ahmedabad, 21 March, 2026 – Zydus Lifesciences Limited has launched Semaglutide Injection in India under the brand names SEMAGLYN™ , MASHEMA™ and ALTERME™ following patent expiry. The Drug Controller General of India (DCGI) previously approved the manufacturing and marketing of the injection for the treatment of Type 2 Diabetes Mellitus and Obesity.The company is introducing an innovative, reusable multi-dose pen device. This device allows clinicians and patients to conveniently select and administer different dose strengths from a single pen, improving adherence, enhancing convenience, and lowering the overall cost of therapy. Zydus’ Semaglutide injection will...

Delhivery Limited Receives NCLT Approval for Amalgamation of Spoton Logistics Delhivery Limited announced on March 21, 2026, that the Hon'ble National Company Law Tribunal (NCLT), New Delhi, has approved the Scheme of Amalgamation involving Spoton Logistics Private Limited (SLPL) and Spoton Supply Chain Solutions Private Limited (SSCSPL) into Delhivery Limited. The order was issued on March 20, 2026.The Appointed Date for the scheme is April 1, 2025. The amalgamation will take effect upon filing of a certified true copy of the order with the Registrar of Companies.The Scheme involves the transfer of the entire business and undertaking of SLPL and SSCSPL to Delhivery Limited. The NCLT’s decision follows a prior application disposed...

Belrise Industries Limited Issues Commercial Paper for Rs. 100 Crores Belrise Industries Limited announced the issuance of commercial paper totaling Rs. 100 crores through a private placement on March 20, 2026. The placement follows an earlier intimation dated January 31, 2026.The commercial paper has a tenure of 12 months, maturing on March 20, 2027. It carries an interest rate of 8% per annum, payable in a bullet payment at maturity. The paper was issued to Karur Vysya Bank Limited and is unsecured. Crisil has assigned a credit rating of Crisil A1+ to the commercial paper.Details of the issuance are summarized below:ParticularsDetailsIssue SizeRs. 100 CroresListingNot ListedTenure12 MonthsAllotment Date20/03/2026...

Fractal Analytics Ltd. Approves Business Unit Transfer, Investments, and Governance Updates Fractal Analytics Ltd. announced several key decisions following a board meeting held on March 20, 2026. The company approved the sale and transfer of its EdTech, Fractal Analytics Academy (FAA), and Iqigai.ai business units to Analytics Vidhya Educon Private Limited (AVEPL), a wholly owned subsidiary, for an aggregate consideration of INR 10.9 crore. The transaction, effective April 1, 2026, is subject to adjustments based on the terms of the Business Transfer Agreement.In addition, Fractal Analytics approved an investment of INR 39.4 crore in equity shares of AVEPL, also a wholly owned subsidiary. The company also increased the investment...

Orient Green Power Reports Progress on Wind Turbine Project Orient Green Power Company Limited announced on March 21, 2026, that its subsidiary, Gamma Green Power Private Limited, has completed the erection of two 3.3 MW wind turbine generators (WTGs) manufactured by Envision, totaling 6.6 MW in capacity. The project, located in Tiruchirappalli District, Tamil Nadu, involves a turnkey Engineering, Procurement and Construction (EPC) contract with Renfra Energy India Limited.Gamma received service connection for the completed WTGs on March 20, 2026. Remaining procedural formalities are underway, with full commissioning expected shortly. Implementation of the remaining 3.3 MW capacity is currently in progress.This development signifies...

New Delhi Television Limited Updates Timeline for 'GoodTimes' Channel Acquisition New Delhi Television Limited announced an update regarding the acquisition of the business undertaking comprising the 'GoodTimes' Channel from Lifestyle & Media Broadcasting Limited. The acquisition, previously disclosed on September 19, 2025, and December 18, 2025, is currently underway and is now anticipated to be completed within approximately three months.The completion of the transaction remains contingent on obtaining necessary statutory and regulatory approvals and fulfilling standard conditions precedent.Source:

H.G. Infra Engineering Limited Completes Sale of Subsidiary H.G. Infra Engineering Limited announced the transfer of its 100% equity stake in H.G. Khammam Devarapalle PKG-2 Private Limited to Neo Infra Income Opportunities Fund on March 20, 2026. This follows previous announcements on August 13, 2025, and December 26, 2025, regarding the planned sale.The transaction concluded with a total consideration of ₹ 213.85 crore. The company received an initial tranche of ₹ 47.63 crore on March 20, 2026, with a second tranche expected.H.G. Khammam Devarapalle PKG-2 Private Limited contributed ₹ 287.58 crore, or 5.7%, to the company’s consolidated revenue for the financial year ended March 31, 2025. The subsidiary’s net worth as of March 31...

Airfloa Rail Technology Ltd. Secures ₹ 22.91 Crores Order from BEML Limited Airfloa Rail Technology Limited announced it has received a new order valued at ₹ 22.91 Crores from BEML Limited, Bangalore, on March 20, 2026.The order involves the design, manufacture, supply, testing, and commissioning of lighting systems, including CMC spares and tools, for the Cars of the Chennai Metro Rail Project - Phase -II. The total order value is ₹ 22.91 Crores, with payment terms stipulating 100% payment within 45 days of each supply. The delivery period is slated to commence in November 2026 and is expected to be completed within 17 months. Inspection of the goods will be conducted by BEML at their premises.According to details released, the...

Nuvoco Vistas Corp. Ltd. Executes Agreements Related to Series B CCDs Nuvoco Vistas Corporation Limited announced on March 20, 2026, that it executed securities subscription and debenture trustee agreements, along with an option agreement, in relation to Series B Compulsorily Convertible Debentures (CCDs). These agreements involve the company, its wholly-owned subsidiary Vadraj, the Debenture Trustee acting for the investors, and Niyogi Enterprise Private Limited.The proceeds from the issuance of the Series B CCDs will be used to repay amounts due to the company for financial assistance provided to Vadraj and to cover costs associated with the issuance.Key Details of the Option Agreement:ParticularsDetailsPartiesThe Company...

Alkem Laboratories Receives EU GMP Certificate for Daman Facility Alkem Laboratories Limited announced on March 21, 2026, that it has received a 'Certificate of GMP Compliance of a Manufacturer' from the Malta Medicines Authority for its manufacturing facility located in Daman, India. This follows a GMP inspection by the Malta Medicines Authority that occurred on December 9, 2025.The certificate is valid for three years from the date of inspection. The facility’s GMP compliance is crucial for continued operations and exports within the European Union. A copy of the certificate will be available on the company’s website.Source:

Glenmark Pharmaceuticals Launches GLIPIQ Ⓡ (Semaglutide) in India, Setting New Affordability Benchmark Mumbai, India, March 21, 2026: Glenmark Pharmaceuticals Ltd (Glenmark) announced the launch of GLIPIQ Ⓡ (semaglutide) in India for the management of Type 2 Diabetes Mellitus (T2DM). The launch aims to improve affordability and expand access to advanced diabetes treatment for patients.GLIPIQ Ⓡ is available in both vial and pre-filled pen formulations and has been approved by the Central Drugs Standard Control Organization (CDSCO) following a Phase III clinical study in India. The vial-based formulation, with dose-specific syringes, is intended to offer a more accessible and flexible approach to GLP-1 therapy and a cost-effective...

Waaree Energies Limited Announces Key Personnel for Materiality Determinations and Disclosures Waaree Energies Limited has announced the Key Managerial Personnel (KMP) authorized to determine the materiality of events and information, as well as those responsible for making disclosures to stock exchanges. The announcement, made on March 20, 2026, outlines the individuals designated under Regulation 30(5) of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015.The individuals authorized to determine materiality include Mr. Hitesh Doshi, Chairman and Managing Director; Mr. Hitesh Mehta, Whole-time Director; Mr. Jignesh Rathod, Whole-time Director and CEO; and Mr. Abhishek...

Transworld Shipping Lines Limited Signs Agreement to Sell Vessel M.V. SSL Krishna Transworld Shipping Lines Limited (formerly known as Shreyas Shipping & Logistics Ltd) announced on March 20, 2026, that it has entered into a Memorandum of Agreement (MOA) to sell one vessel, M.V. SSL Krishna, to Avana Logistek Limited. The consideration for the sale is USD 11.90 million.Source: